Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring

Publicaties

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis

Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop

The Association Between Clinical Outcome and Expression of DNMT1, 3A, and 3B in Locally Advanced Laryngeal Carcinomas Treated by Definitive Radiotherapy

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology

Pers/media

Delivering molecular pathology at lower costs

Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging